Marizyme (MRZM) Stock Statistics & Valuation Metrics

Marizyme has a market cap or net worth of $132.00. The enterprise value is $20.65M.

Marizyme has 131,793,090 shares outstanding. The number of shares has decreased by -2.65% in one year.

Marizyme’s return on equity (ROE) is 14.92 and return on invested capital (ROIC) is -175.14%.

The current PE Ratio of Marizyme is ―. Marizyme’s PEG ratio is -0.00104.

In the last 12 months, Marizyme had revenue of 645.81K and earned -69.54M in profits. Earnings per share was -1.53.

In the last 12 months, operating cash flow was -3.84M and capital expenditures 4.00, giving a free cash flow of -3.84M billion.

Marizyme pays an annual dividend of ―, resulting in a dividend yield of ―

Marizyme upcoming earnings date is Dec 23, 2021, TBA (Confirmed).

Marizyme as a current ratio of 0.04, with Debt / Equity ratio of -445.38%

In the past 12 months, Marizyme has paid 4.19M in taxes.

Marizyme EV to EBITDA ratio is -0.45, with an EV/FCF ratio of -5.37.

Marizyme has $63.73K in cash and marketable securities with $26.66M in debt, giving a net cash position of -$26.59M billion.

Gross margin is 36.99%, with operating margin of -5278.10%, and net profit margin of -10767.77%.

The average price target for Marizyme is ―, which is 11.43% higher than the current price. The consensus rating is ―